Literature DB >> 16046418

Review article: Acute serious and fatal reactions to contrast media: our current understanding.

S K Morcos1.   

Abstract

Serious or fatal reactions to a contrast medium (CM) are unpredictable but fortunately rare. History of serious reaction to CM, bronchial asthma or multiple allergies increases the incidence of serious reactions by a factor of 5. Serious or fatal reaction to CM could be due to direct effect on basophils and mast cells or IgE mediated (type 1 hypersensitivity reaction). Activation of the kinin system leading to the formation of bradykinin could also be involved. Complement activation is unlikely to be a primary factor in initiating a serious reaction to CM. Avoiding CM administration in patients at high risk of serious reaction is advisable, but if the administration is deemed essential all precautions should be implemented and measures to treat serious reactions should be readily available. Oxygen supplementation, intravenous administration of physiological fluids and intramuscular injection of 0.5 ml adrenalin (1:1000) should be considered in the first line management of acute anaphylaxis. The ability to assess and treat serious CM reaction effectively is an essential skill that the radiologist should have and maintain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046418     DOI: 10.1259/bjr/26301414

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  24 in total

Review 1.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

2.  Evaluation of adverse reactions to contrast media in the hospital.

Authors:  E-J Kyung; J-H Ryu; E-Y Kim
Journal:  Br J Radiol       Date:  2013-11-04       Impact factor: 3.039

Review 3.  Allergic reactions to iodinated contrast media: premedication considerations for patients at risk.

Authors:  Jennifer G Schopp; Ramesh S Iyer; Carolyn L Wang; Jonelle M Petscavage; Angelisa M Paladin; William H Bush; Manjiri K Dighe
Journal:  Emerg Radiol       Date:  2013-02-21

4.  Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.

Authors:  Xue Li; Heng Liu; Li Zhao; Junling Liu; Li Cai; Lei Liu; Weiguo Zhang
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

Review 5.  Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.

Authors:  Ezekiel Maloney; Ramesh S Iyer; Grace S Phillips; Shina Menon; John J Lee; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 6.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 7.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

8.  Monitoring non-immediate allergic reactions to iodine contrast media.

Authors:  M J Torres; C Mayorga; J A Cornejo-Garcia; S Lopez; P Chaves; C Rondon; T Fernandez; M Blanca
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

9.  Non-contrast 3D time-of-flight magnetic resonance angiography for visualization of intracranial aneurysms in patients with absolute contraindications to CT or MRI contrast.

Authors:  Vijay Yanamadala; Sameer A Sheth; Brian P Walcott; Bradley R Buchbinder; Deidre Buckley; Christopher S Ogilvy
Journal:  J Clin Neurosci       Date:  2013-05-16       Impact factor: 1.961

10.  Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.

Authors:  Vivekanandan Kalaiselvan; Surbhi Sharma; Gyanendra Nath Singh
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.